Full story
  • CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management

    Sep 1, 2020, 11:08 AM by Michael Croft
    LOUVAIN-LA-NUEVE, BELGIUM - Sep 1, 2020 - CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, today announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management
    Full story
  • Racial Impacts of COVID-19, Neutralizing Antibodies, More

    Aug 28, 2020, 10:05 AM by Michael Croft

    Bio-IT World | Racial segregation of COVID-19 is following HIV patterns, more data on neutralizing antibodies, four months of data from Italy's use of hydroxychloroquine, and a computer model for school launches. Plus, an award from the UK government for vaccine development. 

    Full story
  • CD Genomics Introduces Extended Panels for SARS-CoV-2 Detection and Research

    Aug 28, 2020, 01:42 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Aug 28, 2020 - CD Genomics, a leader in sequencing, microarray analysis, library construction and genotyping, recently announced availability of its CDAMP® SARS-CoV-2 Panel Kit, CDCAP® β-CoVs Panel Kit and CDCAP® Respiratory Virus Panel Kit for SARS-CoV-2 detection and research via its predesigend NGS panels
    Full story
  • UK Biobank Contracts With DNAnexus, AWS to Build Data Analysis Platform

    Aug 26, 2020, 14:40 PM by Michael Croft
    Bio-IT World  UK Biobank, a long-term study of health data from 500,000 UK volunteers, announced today that it is developing its own cloud-based Data Analysis Platform to make its extensive medical data available to a broader range of researchers around the world. Funding for the Data Analysis Platform has come from Wellcome, and it will be developed over the next three years by DNAnexus in collaboration with Amazon Web Services (AWS).
    Full story
  • Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners

    Aug 26, 2020, 10:49 AM by Michael Croft
    PRESTON, UNITED KINGDOM - Aug 26, 2020 - Since launching its first site in Preston in North West England in 2019, Panthera continues to expand its network of UK clinical trial sites with a new site in North London in collaboration with a GP Super partnership Medicus Health Partners
    Full story
  • Vertiv, Pure Storage, And More: News From August 2020

    Aug 25, 2020, 15:15 PM by Michael Croft
    Bio-IT World   August featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Vertiv, Pure Storage, and more.
    Full story
  • Aveshka announces Dr. Til Jolly as Chief Medical Officer

    Aug 21, 2020, 21:24 PM by Michael Croft
    WASHINGTON, DC, UNITED STATES - Aug 10, 2020 - Aveshka announced Dr. Til Jolly will join the company’s executive team in the newly created role of Chief Medical Officer (CMO)
    Full story
  • Beetle Viruses, Nitrate Supplements, Missing Sense of Smell: COVID-19 Updates

    Aug 21, 2020, 09:35 AM by Michael Croft
    Bio-IT World | How a beetle virus is informing SARS-CoV-2 research, plus nitrate supplementation for aid breathing, new small molecules active against the virus, and a theory for why COVID-19 patients lose their sense of smell. Plus, $9.8 million from DOD for vaccine research and virus-like particles for vaccine development.
    Full story
  • The Chemistry-Focused Technology Platform Is Optimized at Alfa Chemistry

    Aug 20, 2020, 23:49 PM by Michael Croft
    NY, NY - Aug 19, 2020 - Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management
    Full story
  • AI & Medicine Develops Medical Therapy and Research System to Facilitate Disease Treatment

    Aug 20, 2020, 23:36 PM by Michael Croft
    NY, NY - Aug 20, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces that it has successfully developed a medical therapy and research system, which can assist in disease treatment, health management, adjuvant therapy, and deep mining of public document database
    Full story